Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,02 CAD | 0,00% |
|
0,00% | 0,00% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Simmonds
CEO | Chief Executive Officer | 48 | 16-01-20 |
Rakesh Malhotra
DFI | Director of Finance/CFO | 67 | 01-12-18 |
Anthony Hall
BRD | Director/Board Member | - | 07-08-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Simmonds
CEO | Chief Executive Officer | 48 | 16-01-20 |
Paul Crath
BRD | Director/Board Member | - | 17-08-20 |
Sara Irwin
BRD | Director/Board Member | - | 31-10-18 |
Larry Horwitz
BRD | Director/Board Member | - | 16-01-20 |
Anthony Hall
BRD | Director/Board Member | - | 07-08-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 461 549 269 | 415 377 169 ( 90,00 %) | 0 | 90,00 % |
Bedrijfsgegevens
Aion Therapeutic, Inc.
700 West Georgia Street Suite 2200
V7Y 1K8, Vancouver
+
![Adres Aion Therapeutic Inc.(AION)](https://cdn.zonebourse.com/static/address/55126419.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
0,00% | 6,76 mln. | |
+29,99% | 5,69 mld. | |
-31,99% | 3,53 mld. | |
-0,59% | 3,06 mld. | |
-24,15% | 2,62 mld. | |
-9,23% | 2,29 mld. | |
+42,55% | 1,86 mld. | |
+44,37% | 1,43 mld. | |
-11,29% | 1,41 mld. | |
+42,86% | 1,4 mld. |
- Beurs
- Aandelen
- Koers AION
- Onderneming Aion Therapeutic Inc.